000 | 01389 a2200325 4500 | ||
---|---|---|---|
005 | 20250514010122.0 | ||
264 | 0 | _c20011204 | |
008 | 200112s 0 0 eng d | ||
022 | _a0924-977X | ||
024 | 7 |
_a10.1016/s0924-977x(01)00100-6 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKasper, S | |
245 | 0 | 0 |
_aPanic disorder: the place of benzodiazepines and selective serotonin reuptake inhibitors. _h[electronic resource] |
260 |
_bEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology _cAug 2001 |
||
300 |
_a307-21 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntidepressive Agents _xtherapeutic use |
650 | 0 | 4 |
_aBenzodiazepines _xtherapeutic use |
650 | 0 | 4 | _aComorbidity |
650 | 0 | 4 |
_aDepressive Disorder, Major _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPanic Disorder _xdrug therapy |
650 | 0 | 4 |
_aRandomized Controlled Trials as Topic _xstatistics & numerical data |
650 | 0 | 4 |
_aSerotonin _xmetabolism |
650 | 0 | 4 |
_aSelective Serotonin Reuptake Inhibitors _xtherapeutic use |
700 | 1 | _aResinger, E | |
773 | 0 |
_tEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology _gvol. 11 _gno. 4 _gp. 307-21 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0924-977x(01)00100-6 _zAvailable from publisher's website |
999 |
_c11456263 _d11456263 |